These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 11590842)
21. Primary pulmonary hypertension after amfepramone (diethylpropion) with BMPR2 mutation. Abramowicz MJ; Van Haecke P; Demedts M; Delcroix M Eur Respir J; 2003 Sep; 22(3):560-2. PubMed ID: 14516151 [TBL] [Abstract][Full Text] [Related]
22. Primary pulmonary hypertension is associated with reduced pulmonary vascular expression of type II bone morphogenetic protein receptor. Atkinson C; Stewart S; Upton PD; Machado R; Thomson JR; Trembath RC; Morrell NW Circulation; 2002 Apr; 105(14):1672-8. PubMed ID: 11940546 [TBL] [Abstract][Full Text] [Related]
23. Linkage analysis in a large family with primary pulmonary hypertension: genetic heterogeneity and a second primary pulmonary hypertension locus on 2q31-32. Janssen B; Rindermann M; Barth U; Miltenberger-Miltenyi G; Mereles D; Abushi A; Seeger W; Kübler W; Bartram CR; Grünig E Chest; 2002 Mar; 121(3 Suppl):54S-56S. PubMed ID: 11893685 [No Abstract] [Full Text] [Related]
24. Primary pulmonary hypertension in children may have a different genetic background than in adults. Grünig E; Koehler R; Miltenberger-Miltenyi G; Zimmermann R; Gorenflo M; Mereles D; Arnold K; Naust B; Wilkens H; Benz A; von Hippel A; Ulmer HE; Kübler W; Katus HA; Bartram CR; Schranz D; Janssen B Pediatr Res; 2004 Oct; 56(4):571-8. PubMed ID: 15295086 [TBL] [Abstract][Full Text] [Related]
25. Identification of a novel mutation in the gene for bone morphogenetic protein receptor II in an Israeli patient with familial primary pulmonary hypertension. Cahn A; Meiner V; Leitersdorf E; Berkman N Isr Med Assoc J; 2004 Mar; 6(3):156-9. PubMed ID: 15055271 [TBL] [Abstract][Full Text] [Related]
33. Implications of mutations of activin receptor-like kinase 1 gene (ALK1) in addition to bone morphogenetic protein receptor II gene (BMPR2) in children with pulmonary arterial hypertension. Fujiwara M; Yagi H; Matsuoka R; Akimoto K; Furutani M; Imamura S; Uehara R; Nakayama T; Takao A; Nakazawa M; Saji T Circ J; 2008 Jan; 72(1):127-33. PubMed ID: 18159113 [TBL] [Abstract][Full Text] [Related]
35. Gross BMPR2 gene rearrangements constitute a new cause for primary pulmonary hypertension. Cogan JD; Vnencak-Jones CL; Phillips JA; Lane KB; Wheeler LA; Robbins IM; Garrison G; Hedges LK; Loyd JE Genet Med; 2005 Mar; 7(3):169-74. PubMed ID: 15775752 [TBL] [Abstract][Full Text] [Related]
36. HIV-1 TAT represses transcription of the bone morphogenic protein receptor-2 in U937 monocytic cells. Caldwell RL; Gadipatti R; Lane KB; Shepherd VL J Leukoc Biol; 2006 Jan; 79(1):192-201. PubMed ID: 16282533 [TBL] [Abstract][Full Text] [Related]
37. Bone morphogenetic protein receptor-2 and pulmonary arterial hypertension: unraveling a riddle inside an enigma? Stewart DJ Circ Res; 2005 May; 96(10):1033-5. PubMed ID: 15920025 [No Abstract] [Full Text] [Related]
38. Pulmonary veno-occlusive disease caused by an inherited mutation in bone morphogenetic protein receptor II. Runo JR; Vnencak-Jones CL; Prince M; Loyd JE; Wheeler L; Robbins IM; Lane KB; Newman JH; Johnson J; Nichols WC; Phillips JA Am J Respir Crit Care Med; 2003 Mar; 167(6):889-94. PubMed ID: 12446270 [TBL] [Abstract][Full Text] [Related]
40. Investigation of second genetic hits at the BMPR2 locus as a modulator of disease progression in familial pulmonary arterial hypertension. Machado RD; James V; Southwood M; Harrison RE; Atkinson C; Stewart S; Morrell NW; Trembath RC; Aldred MA Circulation; 2005 Feb; 111(5):607-13. PubMed ID: 15699281 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]